Also published in ncbi.nlm.nih.gov:
Characterization of Transfusion-Derived Iron Deposition in Childhood Cancer Survivors.
x hide permanently

Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA.

ncbi.nlm.nih.gov

Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA.

Pediatr Res. 2017 Apr 18;:

Authors: Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N

Abstract BACKGROUND: Neuroblastoma is the second most common extracranial cancer in children.